Biotechnology Developments For Industry, S Sample Clauses

Biotechnology Developments For Industry, S. L., a Spanish limited liability company, with registered office in Xxxxxxx Xxxxxxxxx Xxxxxx, 8, 47151, Boecillo (Valladolid), holder of Spanish tax identification number B47729934 (“BDI Holding” or the “Company”), represented by Xx. Xxxxx Xxxxxxxxx Gómez, of legal age, with Spanish nationality, holding taxpayer identification number , in force, and domiciled for this purposes in , Boecillo. He acts in his capacity of Chief Executive Officer of BDI Holding.
AutoNDA by SimpleDocs
Biotechnology Developments For Industry, S. L., a Spanish limited liability company, with registered office in Xxxxxxx Xxxxxxxxx Xxxxxx, 8, 47151, Boecillo (Valladolid), holder of Spanish tax identification number B47729934 ("BDI Holding" or the "Company"), represented by Xx. Xxxxx Xxxxxxxxx Gómez, of legal age, with Spanish nationality, holding taxpayer identification number , in force, and domiciled for this purposes in Xxxxx Xxxxxx 13, Boecillo. He acts in his capacity of Chief Executive Officer of BDI Holding. Finally, the Shareholders and the Company shall be jointly referred to as the "Parties" and each one of them as a "Party''. In the capacity in which they act, the Parties reciprocally recognize each other to have the necessary and sufficient legal capacity and powers of representation to enter into this Shareholders Agreement (hereinafter this "Agreement”) and for this purpose, they state the following
Biotechnology Developments For Industry, S. L., a Spanish limited liability company, with registered office in Xxxxxxx Xxxxxxxxx Xxxxxx, 8, 47151, Boecillo (Valladolid), holder of Spanish tax identification number B47729934 ("BDI Holding"), represented by Xx. Xxxxx Xxxxxxxxx G6mez., of legal age, with Spanish nationality, holding taxpayer identification number (70.868.817 K), in force, and domiciled for this purposes in Xxxxx Xxxxxx 13, Boecillo. He acts in his capacity of Chief Executive Officer of BDI Holding. Hereinafter the persons and companies identified in items (1) and (2) will be jointly referred to as the "Investors". Hereinafter the persons and companies identified in items (1) through (3) will be jointly referred to as the “Shareholders". AND OF ANOTHER PART

Related to Biotechnology Developments For Industry, S

  • Technology License 4.1 Unless any event described in Article 2.2 or 2.3 of this Agreement occurs, all of the technology required to be licensed for any of Party B’s business shall be provided by Party A on an exclusive basis. Party A will try its best to license Party B to use the technology owned by Party A, or re-license Party B to use the technology as approved by the owner.

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Information Technology The Company’s and the Subsidiaries’ information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) operate and perform in all material respects as required in connection with the operation of the business of the Company and the Subsidiaries as currently conducted. The Company, and the Subsidiaries maintain commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and all personal, personally identifiable, sensitive, confidential or regulated data (“Personal Data”) processed and stored thereon, and to the knowledge of the Company, there have been no breaches, incidents, violations, outages, compromises or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification, except for any such noncompliance that would not have a Material Adverse Effect.

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Technology For purposes of this Agreement, “Technology” means all Software, information, designs, formulae, algorithms, procedures, methods, techniques, ideas, know-how, research and development, technical data, programs, subroutines, tools, materials, specifications, processes, inventions (whether or not patentable and whether or not reduced to practice), apparatus, creations, improvements and other similar materials, and all recordings, graphs, drawings, reports, analyses, and other writings, and other embodiments of any of the foregoing, in any form or media whether or not specifically listed herein. Further, for purposes of this Agreement, “Software” means any and all computer programs, whether in source code or object code; databases and compilations, whether machine readable or otherwise; descriptions, flow-charts and other work product used to design, plan, organize and develop any of the foregoing; and all documentation, including user manuals and other training documentation, related to any of the foregoing.

  • Joint Development All inventions, know-how, trade secrets, data or information which result from joint development by the Parties hereto shall be jointly owned by the Parties. The Parties hereby agree to cooperate in good faith in the filing of any and all patent applications in all jurisdictions.

  • Status as Business Development Company The Borrower is an “investment company” that has elected to be regulated as a “business development company” within the meaning of the Investment Company Act and qualifies as a RIC.

Time is Money Join Law Insider Premium to draft better contracts faster.